미국의 N95 마스크 시장 : 시장 규모, 점유율, 동향 분석 보고서 - 제품별, 유통 채널별, 최종 용도별, 부문별 예측(2025-2030년)

U.S. N95 Masks Market Growth & Trends:

The U.S. N95 masks market size is estimated to reach USD 1.28 billion by 2030, registering a CAGR of 8.4% from 2025 to 2030, according to a new report by Grand View Research, Inc. The rising cases of infectious biological diseases worldwide, stringent mask regulations, and worker safety, are expected to drive market growth.

The N95 mask industry is expanding rapidly in many countries such as the U.S. and Canada. These are used extensively in a variety of industries, including biotechnology, pharmaceuticals healthcare, construction, manufacturing, mining, and oil & gas. These can also prevent micron-sized particles from entering the human respiratory system and oral cavity.

Local, regional, and international manufacturers have increased mask production capacity to meet the rising demand. The pandemic has also created opportunities for start-ups to enter and expand their reach in this market. Furthermore, governments in various countries are regulating the prices of N95 Mask to maintain public access to these masks.

The presence of a huge healthcare system in the U.S. and the growing e-commerce industry have compelled retail pharmacies to develop new strategies. Pharmacy chains such as Walgreens and Rite Aid have been aggressively expanding their operations throughout the country with 24/7 availability and pickups at alternate locations.

The manufacturers have partnered with distributors for expanding their market reach in various regions. N95 Mask are distributed globally to end-users through online and offline distribution channels. Some of the key distributors include Henry Schein, Inc.; Fisher Scientific; VWR International, LLC; Amazon.com, Inc.; W.W. Grainger, Inc.; and Westnet, Inc.

The market for N95 Mask is characterized by the presence of well-established players that have a broad product portfolio, extensive distribution networks, and large financial capacities, which is expected to restrict new entrants. However strategic product differentiation by the manufacturers is anticipated to help in achieving market dominance.

U.S. N95 Masks Market Report Highlights:

• The without-exhalation valve segment accounted for 71.44% of the revenue share in 2024. N95 Mask provide a high level of protection during inhaling and exhalation and they can also limit at least 95% of very small test particles
• The offline distribution channel segment is expected to expand significantly at a CAGR of 6.5% over the forecast period. Physical locations provide immediate access for customers seeking protection from airborne pathogens or particulate matter.
• The healthcare end-use segment is likely to register the highest CAGR of 12.0% over the forecast period. N95 Mask played a crucial role for first responders, healthcare workers, and other essential workers.
• The demand for N95 Mask in construction led the U.S. market and accounted for a revenue share of 30.86% in 2024. N95 Mask are highly recommended for use in the construction and manufacturing industry, to assure worker safety.
• In June 2021, Aegle launched NIOSH certified N95 mask with Acteev anti-microbial fabric as well as authentication and NFC chip embedded traceability technology to prevent counterfeiting of masks.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1. Purchased Database
  • 1.3.2. GVR's Internal Database
  • 1.3.3. Secondary Sources & Third-Party Perspectives
  • 1.3.4. Primary Research
• 1.4. Information Analysis
  • 1.4.1. Data Analysis Models
• 1.5. Market Formulation & Data Visualization
• 1.6. Data Validation & Publishing

Chapter 2. Executive Summary

• 2.1. Market Insights
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. U.S. N95 Masks Market Variables, Trends & Scope

• 3.1. U.S. N95 Masks Market Outlook
• 3.2. Industry Value Chain Analysis
• 3.3. Average Price Trend Analysis
• 3.4. Supply-Demand Gap Analysis, 2024
• 3.5. Regulatory Framework
  • 3.5.1. Policies and Incentive Plans
  • 3.5.2. Standards and Compliances
  • 3.5.3. Regulatory Impact Analysis
• 3.6. Market Dynamics
  • 3.6.1. Market Driver Analysis
  • 3.6.2. Market Restraint Analysis
  • 3.6.3. Industry Challenges
• 3.7. Porter's Five Forces Analysis
  • 3.7.1. Supplier Power
  • 3.7.2. Buyer Power
  • 3.7.3. Substitution Threat
  • 3.7.4. Threat from New Entrant
  • 3.7.5. Competitive Rivalry
• 3.8. PESTEL Analysis
  • 3.8.1. Political Landscape
  • 3.8.2. Economic Landscape
  • 3.8.3. Social Landscape
  • 3.8.4. Technological Landscape
  • 3.8.5. Environmental Landscape
  • 3.8.6. Legal Landscape

Chapter 4. U.S. N95 Masks Market: Product Outlook Estimates & Forecasts

• 4.1. U.S. N95 Masks Market: Product Movement Analysis, 2024 & 2030
  • 4.1.1. With exhalation valve
    • 4.1.1.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • 4.1.2. Without exhalation valve
    • 4.1.2.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)

Chapter 5. U.S. N95 Masks Market: Distribution Channel Outlook Estimates & Forecasts

• 5.1. U.S. N95 Masks Market: Distribution Channel Movement Analysis, 2024 & 2030
  • 5.1.1. Online
    • 5.1.1.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • 5.1.2. Offline

Chapter 6. U.S. N95 Masks Market: End Use Outlook Estimates & Forecasts

• 6.1. U.S. N95 Masks Market: End Use Movement Analysis, 2024 & 2030
  • 6.1.1. Healthcare
    • 6.1.1.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • 6.1.2. Construction
    • 6.1.2.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • 6.1.3. Manufacturing
    • 6.1.3.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • 6.1.4. Oil & Gas
    • 6.1.4.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • 6.1.5. Others
    • 6.1.5.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Vendor Landscape
  • 7.2.1. Company Categorization
  • 7.2.2. List of Key Distributors and Channel Partners
  • 7.2.3. List of Potential Customers/End Users
• 7.3. Competitive Dynamics
  • 7.3.1. Competitive Benchmarking
  • 7.3.2. Strategy Mapping
  • 7.3.3. Heat Map Analysis
• 7.4. Company Profiles/Listing
  • 7.4.1. 3M
    • 7.4.1.1. Participant's Overview
    • 7.4.1.2. Financial Performance
    • 7.4.1.3. Product Benchmarking
    • 7.4.1.4. Strategic Initiatives
  • 7.4.2. Honeywell International Inc.
    • 7.4.2.1. Participant's Overview
    • 7.4.2.2. Financial Performance
    • 7.4.2.3. Product Benchmarking
    • 7.4.2.4. Strategic Initiatives
  • 7.4.3. AlphaProTech
    • 7.4.3.1. Participant's Overview
    • 7.4.3.2. Financial Performance
    • 7.4.3.3. Product Benchmarking
    • 7.4.3.4. Strategic Initiatives
  • 7.4.4. Ansell Ltd.
    • 7.4.4.1. Participant's Overview
    • 7.4.4.2. Financial Performance
    • 7.4.4.3. Product Benchmarking
    • 7.4.4.4. Strategic Initiatives
  • 7.4.5. O&M Halyard
    • 7.4.5.1. Participant's Overview
    • 7.4.5.2. Financial Performance
    • 7.4.5.3. Product Benchmarking
    • 7.4.5.4. Strategic Initiatives
  • 7.4.6. The Gerson Companies
    • 7.4.6.1. Participant's Overview
    • 7.4.6.2. Financial Performance
    • 7.4.6.3. Product Benchmarking
    • 7.4.6.4. Strategic Initiatives
  • 7.4.7. Cardinal Health
    • 7.4.7.1. Participant's Overview
    • 7.4.7.2. Financial Performance
    • 7.4.7.3. Product Benchmarking
    • 7.4.7.4. Strategic Initiatives
  • 7.4.8. Medline Industries, LP
    • 7.4.8.1. Participant's Overview
    • 7.4.8.2. Financial Performance
    • 7.4.8.3. Product Benchmarking
    • 7.4.8.4. Strategic Initiatives
  • 7.4.9. Moldex-Metric
    • 7.4.9.1. Participant's Overview
    • 7.4.9.2. Financial Performance
    • 7.4.9.3. Product Benchmarking
    • 7.4.9.4. Strategic Initiatives
  • 7.4.10. Prestige Ameritech
    • 7.4.10.1. Participant's Overview
    • 7.4.10.2. Financial Performance
    • 7.4.10.3. Product Benchmarking
    • 7.4.10.4. Strategic Initiatives